The core provides state-of-the-art high-quality research assays, especially useful for clinical research, to the investigators at reduced costs. The list of assays offered by the core may found in the core website.
The Center for Advanced Molecular Diagnostics (CAMD) is a CLIA-certified Clinical Molecular Diagnostics Laboratory. Our mission is to provide high quality innovative molecular genetic diagnostic services to support the patient care missions of clinicians and clinical researchers.
This core provides research investigators with experienced research staff to assist in the start-up, implementation, and close out of clinical research studies. Services provided include Biostatistics, Nursing and Nutrition, Outpatient services and Research coordination.
We are the research arm of the Center for Integrated Diagnostics (CID) at MGH. We provide molecular diagnostics assays and help with clinical trials, early translation all the way to clinical validation, integration and utility assessment in practice.
The Circulating Tumor Cell (CTC) core provides users with FDA-approved method for the isolation and quantitation of circulating tumor cells from peripheral blood samples of patients with metastatic cancers.
The Clinical Research Center provides Nursing, Metabolism and Nutrition, and Lab support services to the MGH and affiliated communities. Our clinical unit is capable of supporting a wide variety of both inpatient and outpatient research studies, as well as ancillary lab assay support.
The core provides investigators with the necessary expertise and resources to design and undertake pharmacokinetic studies in the context of phase I and phase II clinical trials, and preclinical investigations.
This core provides frozen fecal material for transplantation for treatment of recurrent colitis, especially C. difficile colitis.
The HSDRC provides access to fresh and banked human skin specimens and cutting edge techniques for analysis of human skin including CyTOF mass cytometry, multiplex immunofluorescence microscopy, T cell receptor sequencing, and NanoString gene expression analysis.
Breaking down barriers to translational research is the key to finding new approaches to inflammatory arthritis in adults and children.
The Core provides site-related services for multi-site research under the oversight of the Mass General Brigham IRB.
This core provides flexible morphometric measurement service, especially neuroanatomic morphometry, to meet the needs of the clinical community. It operates in conjunction with Martinos center for Imaging.
This core custom generates cDNA clones and shRNA lentiviral constructs for investigators.
The Laboratory for Molecular Medicine (LMM) is a CLIA-certified molecular diagnostic laboratory, operated by Partners HealthCare Personalized Medicine.Ê
The core provides high quality pharmaceutical services to the research community and supports growth of McLean HospitalŠ—Ès clinical research portfolio.
The Sleep & EEG Core within the Division of Sleep Medicine (DSM) provides an integrated infrastructure and knowledge base in support of research projects that use polysomnography (PSG), quantitative EEG analysis and related methodologies
The Translational Discovery Laboratory (Core) provides state of the art facility and trained staff for large animal experimentation with an emphasis on percutaneous cardiovascular technologies.
The Translation Research Center provides support for industry-sponsored clinical trials for MGH investigators. Our clinical unit is capable of supporting a wide variety of both inpatient and outpatient research studies, as well as providing project management, regulatory, and research coordinator support.